<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37848295</PMID><DateCompleted><Year>2023</Year><Month>10</Month><Day>23</Day></DateCompleted><DateRevised><Year>2023</Year><Month>10</Month><Day>23</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2044-6055</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>10</Issue><PubDate><Year>2023</Year><Month>Oct</Month><Day>17</Day></PubDate></JournalIssue><Title>BMJ open</Title><ISOAbbreviation>BMJ Open</ISOAbbreviation></Journal><ArticleTitle>Prognosis of patients with long COVID symptoms: a protocol for a longitudinal cohort study at a primary care referred outpatient clinic in Helsinki, Finland.</ArticleTitle><Pagination><StartPage>e072935</StartPage><MedlinePgn>e072935</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e072935</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1136/bmjopen-2023-072935</ELocationID><Abstract><AbstractText Label="INTRODUCTION">After COVID-19, many continue to experience persistent debilitating symptoms, that is, long COVID. Its most prevalent symptoms are chest pain, difficulties with breathing, painful muscles, ageusia or anosmia, tingling extremities and general tiredness. This paper describes the protocol of the Long COVID Cohort Study to assess the prognosis and prognostic determinants of patients with long COVID by implementing patient-reported outcome measures (PROMs), patient-reported experience measures (PREMs) and clinical examinations during a 1-year follow-up.</AbstractText><AbstractText Label="METHODS AND ANALYSIS">This is a prospective, single-site cohort study consisting of administering questionnaires and clinical examinations to adult patients referred to the Clinic for Long-Term Effects of COVID-19 at Helsinki University Hospital (Hospital district of Helsinki and Uusimaa). The referrals are from all healthcare units within HUS and other hospital districts during years 2021-2023. All admitted patients have had laboratory-confirmed COVID-19. The targeted study sample size is 500 participants. The questionnaires are administered at 0, 3, 6 and 12&#x2009;months. The main outcome variables are the changes in self-reported functional abilities and quality of life. In addition, we will evaluate functional abilities at baseline using neurocognitive evaluation, a 6MWT and a measurement of hand grip strength. The Long COVID Cohort Study will form a quality register for the clinic and characterise the first systematic collection of PROMs, PREMs, questionnaire and clinical examinations related to long COVID in Finland. The Study belongs to a study consortium Long COVID-HORIZON-HLTH-2021-DISEASE-04 that aims to reveal the biomechanisms of long COVID.</AbstractText><AbstractText Label="ETHICS AND DISSEMINATION">This study has been approved by the Helsinki University Hospital research ethics committee board, ID HUS/1493/2021 on 6 March 2021. All study participants sign written informed consent for participation. The study findings will be reported for publication in peer-reviewed journals.</AbstractText><AbstractText Label="TRIAL REGISTRATION NUMBER">NCT05699512; Pre-results.</AbstractText><CopyrightInformation>&#xa9; Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Virrantaus</LastName><ForeName>H&#xe9;l&#xe8;ne</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0001-6044-0217</Identifier><AffiliationInfo><Affiliation>Outpatient Clinic for Long-Term Effects of COVID-19, Helsinki University Central Hospital, Helsinki, Finland lene294@hotmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liira</LastName><ForeName>Helena</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Outpatient Clinic for Long-Term Effects of COVID-19, Helsinki University Central Hospital, Helsinki, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Posharina</LastName><ForeName>Tatiana</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Outpatient Clinic for Long-Term Effects of COVID-19, Helsinki University Central Hospital, Helsinki, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sulg</LastName><ForeName>Aleksandra</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Outpatient Clinic for Long-Term Effects of COVID-19, Helsinki University Central Hospital, Helsinki, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>M&#xe4;ntyl&#xe4;</LastName><ForeName>Teemu</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Outpatient Clinic for Long-Term Effects of COVID-19, Helsinki University Central Hospital, Helsinki, Finland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Brain Centre, Psychiatry, Helsinki University Central Hospital, Helsinki, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kanerva</LastName><ForeName>Mari</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Hospital Hygiene and Infection Control, TYKS Turku University Hospital, Turku, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Laakso</LastName><ForeName>Sini</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Clinical Neurosciences, Neurology, Helsinki University Central Hospital, Helsinki, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sainio</LastName><ForeName>Markku</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Outpatient Clinic for Functional Disorders, Helsinki University Central Hospital, Helsinki, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Malmivaara</LastName><ForeName>Antti</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-9042-4450</Identifier><AffiliationInfo><Affiliation>Centre for Health and Social Economics, National Institute for Health and Welfare, Helsinki, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vuokko</LastName><ForeName>Aki</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Occupational Medicine, Finnish Institute of Occupational Health, Helsinki, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Varonen</LastName><ForeName>Mikko</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Outpatient Clinic for Long-Term Effects of COVID-19, Helsinki University Central Hospital, Helsinki, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ven&#xe4;l&#xe4;inen</LastName><ForeName>Mikko</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-1777-4259</Identifier><AffiliationInfo><Affiliation>Department of Medical Physics, University of Turku, Turku, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arokoski</LastName><ForeName>Jari</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Physical and Rehabilitation Medicine, Helsinki University Central Hospital, Helsinki, Finland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgery, Helsingin yliopisto, Helsinki, Finland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT05699512</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>10</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMJ Open</MedlineTA><NlmUniqueID>101552874</NlmUniqueID><ISSNLinking>2044-6055</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008137" MajorTopicYN="N">Longitudinal Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005387" MajorTopicYN="N" Type="Geographic">Finland</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018737" MajorTopicYN="N">Hand Strength</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000554" MajorTopicYN="N">Ambulatory Care Facilities</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011320" MajorTopicYN="N">Primary Health Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Prognosis</Keyword><Keyword MajorTopicYN="N">Quality of Life</Keyword><Keyword MajorTopicYN="N">REHABILITATION MEDICINE</Keyword></KeywordList><CoiStatement>Competing interests: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>10</Month><Day>23</Day><Hour>1</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>10</Month><Day>18</Day><Hour>0</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>10</Month><Day>17</Day><Hour>21</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>10</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37848295</ArticleId><ArticleId IdType="pmc">PMC10582861</ArticleId><ArticleId IdType="doi">10.1136/bmjopen-2023-072935</ArticleId><ArticleId IdType="pii">bmjopen-2023-072935</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hallek M, Adorjan K, Behrends U, et al. . Post-COVID syndrome. Dtsch Arztebl Int 2023;120:48&#x2013;55. 10.3238/arztebl.m2022.0409</Citation><ArticleIdList><ArticleId IdType="doi">10.3238/arztebl.m2022.0409</ArticleId><ArticleId IdType="pmc">PMC10060997</ArticleId><ArticleId IdType="pubmed">36633452</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandmann FG, Tessier E, Lacy J, et al. . Long-term health-related quality of life in non-hospitalized Coronavirus disease 2019 (COVID-19) cases with confirmed severe acute respiratory syndrome Coronavirus 2 (SARS-Cov-2) infection in England: longitudinal analysis and cross-sectional comparison with controls. Clin Infect Dis 2022;75:e962&#x2013;73. 10.1093/cid/ciac151</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciac151</ArticleId><ArticleId IdType="pmc">PMC8903473</ArticleId><ArticleId IdType="pubmed">35245941</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-Las-Pe&#xf1;as C, Notarte KI, Peligro PJ, et al. . Long-COVID symptoms in individuals infected with different SARS-Cov-2 variants of concern: A systematic review of the literature. Viruses 2022;14:2629. 10.3390/v14122629</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14122629</ArticleId><ArticleId IdType="pmc">PMC9785120</ArticleId><ArticleId IdType="pubmed">36560633</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano JB, Murthy S, Marshall JC, et al. . A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis 2022;22:e102&#x2013;7. 10.1016/S1473-3099(21)00703-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballering AV, van Zon SKR, Olde Hartman TC, et al. . Lifelines Corona research initiative. persistence of somatic symptoms after COVID-19 in the Netherlands: an observational cohort study. Lancet 2022;400:452&#x2013;61. 10.1016/S0140-6736(22)01214-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)01214-4</ArticleId><ArticleId IdType="pmc">PMC9352274</ArticleId><ArticleId IdType="pubmed">35934007</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldstein DS. The extended autonomic system, Dyshomeostasis, and COVID-19. Clin Auton Res 2020;30:299&#x2013;315. 10.1007/s10286-020-00714-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10286-020-00714-0</ArticleId><ArticleId IdType="pmc">PMC7374073</ArticleId><ArticleId IdType="pubmed">32700055</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Skorniewska Z, Hampshire A, et al. . Acute blood biomarker profiles predict cognitive deficits 6 and 12 months after COVID-19 hospitalization. Nat Med 2023;31:1. 10.1038/s41591-023-02525-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-023-02525-y</ArticleId><ArticleId IdType="pmc">PMC10579097</ArticleId><ArticleId IdType="pubmed">37653345</ArticleId></ArticleIdList></Reference><Reference><Citation>Engelmann P, L&#xf6;we B, Brehm TT, et al. . Risk factors for worsening of somatic symptom burden in a prospective cohort during the COVID-19 pandemic. Front Psychol 2022;13:1022203. 10.3389/fpsyg.2022.1022203</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyg.2022.1022203</ArticleId><ArticleId IdType="pmc">PMC9631939</ArticleId><ArticleId IdType="pubmed">36337508</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO living guideline, Available: https://app.magicapp.org/#/guideline/6471</Citation></Reference><Reference><Citation>Matheson LN, Isernhagen SJ, Hart DL. Relationships among lifting ability, grip force and return to work. Phys Ther 2002;82:249&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pubmed">11869153</ArticleId></ArticleIdList></Reference><Reference><Citation>Enright PL, Sherrill DL. Reference equations for the six-minute walk in healthy adults. Am J Respir Crit Care Med 1998;158(5 Pt 1):1384&#x2013;7. 10.1164/ajrccm.158.5.9710086</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/ajrccm.158.5.9710086</ArticleId><ArticleId IdType="pubmed">9817683</ArticleId></ArticleIdList></Reference><Reference><Citation>Arabi M, Al-Najjar Y, Sharma O, et al. . Role of previous infection with SARS-Cov-2 in protecting against Omicron Reinfections and severe complications of COVID-19 compared to pre-Omicron variants: a systematic review. BMC Infect Dis 2023;23:432. 10.1186/s12879-023-08328-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-023-08328-3</ArticleId><ArticleId IdType="pmc">PMC10294418</ArticleId><ArticleId IdType="pubmed">37365490</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong SJ, Halim A, Halim M, et al. . Inflammatory and vascular biomarkers in post-COVID-19 syndrome: A systematic review and meta-analysis of over 20 biomarkers. Rev Med Virol 2023;33:e2424. 10.1002/rmv.2424</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2424</ArticleId><ArticleId IdType="pubmed">36708022</ArticleId></ArticleIdList></Reference><Reference><Citation>Ust&#xfc;n TB, Chatterji S, Kostanjsek N, et al. . Developing the world health organization disability assessment schedule 2.0. Bull World Health Organ 2010;88:815&#x2013;23. 10.2471/BLT.09.067231</Citation><ArticleIdList><ArticleId IdType="doi">10.2471/BLT.09.067231</ArticleId><ArticleId IdType="pmc">PMC2971503</ArticleId><ArticleId IdType="pubmed">21076562</ArticleId></ArticleIdList></Reference><Reference><Citation>Power M. EUROHIS: developing common instruments for health surveys. In: Nosikov A, Gudex C, eds. Development of a common instrument for quality of life. Amsterdam, the Netherlands: IOS Press, 2003: 145&#x2013;59.</Citation></Reference><Reference><Citation>Sintonen H. The 15D instrument of health-related quality of life: properties and applications. Ann Med 2001;33:328&#x2013;36. 10.3109/07853890109002086</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/07853890109002086</ArticleId><ArticleId IdType="pubmed">11491191</ArticleId></ArticleIdList></Reference><Reference><Citation>Toussaint A, Murray AM, Voigt K, et al. . Development and validation of the somatic symptom disorder-B criteria scale (SSD-12). Psychosom Med 2016;78:5&#x2013;12. 10.1097/PSY.0000000000000240</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PSY.0000000000000240</ArticleId><ArticleId IdType="pubmed">26461855</ArticleId></ArticleIdList></Reference><Reference><Citation>American Psychiatric Association . Diagnostic and statistical Manual of mental disorders. In: Diagnostic and Statistical Manual of Mental Disorders (DSM-5). 5th ed. Arlington, VA: American Psychiatric Association, 22 May 2013. 10.1176/appi.books.9780890425596</Citation><ArticleIdList><ArticleId IdType="doi">10.1176/appi.books.9780890425596</ArticleId></ArticleIdList></Reference><Reference><Citation>Kroenke K, Spitzer RL, Williams JBW. The PHQ-15: validity of a new measure for evaluating the severity of somatic symptoms. Psychosom Med 2002;64:258&#x2013;66. 10.1097/00006842-200203000-00008</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00006842-200203000-00008</ArticleId><ArticleId IdType="pubmed">11914441</ArticleId></ArticleIdList></Reference><Reference><Citation>Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 2001;16:606&#x2013;13. 10.1046/j.1525-1497.2001.016009606.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1525-1497.2001.016009606.x</ArticleId><ArticleId IdType="pmc">PMC1495268</ArticleId><ArticleId IdType="pubmed">11556941</ArticleId></ArticleIdList></Reference><Reference><Citation>Spitzer RL, Kroenke K, Williams JBW, et al. . A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med 2006;166:1092&#x2013;7. 10.1001/archinte.166.10.1092</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinte.166.10.1092</ArticleId><ArticleId IdType="pubmed">16717171</ArticleId></ArticleIdList></Reference><Reference><Citation>Morin CM, Belleville G, B&#xe9;langer L, et al. . The insomnia severity index: Psychometric indicators to detect insomnia cases and evaluate treatment response. Sleep 2011;34:601&#x2013;8. 10.1093/sleep/34.5.601</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/sleep/34.5.601</ArticleId><ArticleId IdType="pmc">PMC3079939</ArticleId><ArticleId IdType="pubmed">21532953</ArticleId></ArticleIdList></Reference><Reference><Citation>Health 2000 in brief, Available: https://thl.fi/en/web/thlfi-en/research-and-expertwork/projects-and-programmes/health-2000-2011/health-2000-in-brief [Accessed 29 Nov 2020].</Citation></Reference><Reference><Citation>Tuomi K, Ilmarinen J, Jankola A, et al. . Work Ability Index. Finnish Institute of Occupational Health, 1998.</Citation></Reference><Reference><Citation>Tuisku K, Vuokko A, Puustinen N, et al. . Psyykkisen Ty&#xf6;- JA Toimintakyvyn Arviointiin Tarvitaan Yhten&#xe4;isi&#xe4; K&#xe4;yt&#xe4;nteit&#xe4; [Assessment of psychiatric function and work ability]. Suomen L&#xe4;&#xe4;k&#xe4;rilehti 2022:2093&#x2013;6.</Citation></Reference><Reference><Citation>Wagnild G. A review of the resilience scale. J Nurs Meas 2009;17:105&#x2013;13. 10.1891/1061-3749.17.2.105</Citation><ArticleIdList><ArticleId IdType="doi">10.1891/1061-3749.17.2.105</ArticleId><ArticleId IdType="pubmed">19711709</ArticleId></ArticleIdList></Reference><Reference><Citation>Losoi H, Turunen S, W&#xe4;ljas M, et al. . Psychometric properties of the Finnish version of the resilience scale and its short version. PCH 2013;2:1&#x2013;10. 10.5964/pch.v2i1.40</Citation><ArticleIdList><ArticleId IdType="doi">10.5964/pch.v2i1.40</ArticleId></ArticleIdList></Reference><Reference><Citation>Fink P, Rosendal M, eds. Functional disorders and medically unexplained symptoms. Aarhus, Denmark: Aarhus University Press, 2015. 10.2307/jj.608185</Citation><ArticleIdList><ArticleId IdType="doi">10.2307/jj.608185</ArticleId></ArticleIdList></Reference><Reference><Citation>Fink P, Toft T, Hansen MS, et al. . Symptoms and syndromes of bodily distress: an exploratory study of 978 internal medical, neurological and primary care patients. Psychosom Med 2007;69:30&#x2013;9. 10.1097/PSY.0b013e31802e46eb</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PSY.0b013e31802e46eb</ArticleId><ArticleId IdType="pubmed">17244846</ArticleId></ArticleIdList></Reference><Reference><Citation>Benton AL, Hamsher K. Multilingual Aphasia Examination. University of Iowa, 1976.</Citation></Reference><Reference><Citation>Wechsler DA. Wechsler Adult Intelligence Scale 4th edition. San Antonio, TX: Psychological Corporation, 2008.</Citation></Reference><Reference><Citation>Wechsler DA. Wechsler Memory Scale 3rd edition. Psychological Corporation, 1997.</Citation></Reference><Reference><Citation>Reitan RM, Wolfson D. The Halstead-Reitan neuropsychological test battery. Neuropsychological Press, 1985.</Citation></Reference><Reference><Citation>Kaplan E, Goodglass H, Weintraub S. Boston Naming Test. Philadelphia: Lea &amp; Febiger, 1983.</Citation></Reference><Reference><Citation>Gualtieri CT, Johnson LG. Reliability and validity of a computerized Neurocognitive test battery, CNS vital signs. Arch Clin Neuropsychol 2006;21:623&#x2013;43. 10.1016/j.acn.2006.05.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.acn.2006.05.007</ArticleId><ArticleId IdType="pubmed">17014981</ArticleId></ArticleIdList></Reference><Reference><Citation>Tolvanen . Elina: patient Enablement after a single GP consultation in primary health care: measurement validation for patient Enablement in Finland [Dissertation]. Tampereen yliopisto, 2020</Citation></Reference><Reference><Citation>HUS Ethics Committees, Available: https://www.hus.fi/en/about-us/administration-and-decision-making/committees [Accessed 29 Nov 2020].</Citation></Reference><Reference><Citation>Chan A-W, Tetzlaff JM, G&#xf8;tzsche PC, et al. . SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ 2013;346:e7586. 10.1136/bmj.e7586</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.e7586</ArticleId><ArticleId IdType="pmc">PMC3541470</ArticleId><ArticleId IdType="pubmed">23303884</ArticleId></ArticleIdList></Reference><Reference><Citation>Cuschieri S. The STROBE guidelines. Saudi J Anaesth 2019;13(Suppl 1):S31&#x2013;4. 10.4103/sja.SJA_543_18</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/sja.SJA_543_18</ArticleId><ArticleId IdType="pmc">PMC6398292</ArticleId><ArticleId IdType="pubmed">30930717</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>